In Venezuela, systemic analgesics are positioned as products for light and moderate pain and general discomfort. Acetaminophen is commonly positioned as appropriate to treat mild fever and often advertised as “safe” for dengue cases because other common analgesics, such as ibuprofen and aspirin, increase the severity of the symptoms when used for the haemorrhagic variant due to the potential for increased bleeding. Acetaminophen does not carry this risk, so it is the preferred OTC treatment.
The Analgesics in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
The Analgesics in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
ANALGESICS IN VENEZUELAList of Contents and Tables
Headlines
Prospects
Volume Sales of Systemic Analgesics Dominate in 2018
Lower Incidence of Viral Infections Affects Sales of Acetaminophen
Competitive Landscape
Two Domestic Companies Lead Analgesics
Two Multinationals Follow at A Distance
Unstable Presence of Generics Limits Positive Performance
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Hyperinflation Worsens An Already Critical Situation
Negative Growth Rates Continue in Spite of A Slightly Better Supply
Oligopolistic Competition Characterises the Venezuelan Market in 2018
Drugstores/parapharmacies Lead Retail Distribution
Future Performance Hinges on Macroeconomic and Industrial Policies
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
